ストックスクリーナーアプリを入手
1.48
1.37%
0.02
アフターアワーズ：
1.49
0.01
+0.68%
前日終値:
$1.46
開ける：
$1.46
24時間の取引高:
152.59K
Relative Volume:
0.34
時価総額：
$38.66M
収益：
$4.75M
当期純損益:
$-7.83M
株価収益率:
6.7983
EPS:
0.2177
ネットキャッシュフロー:
$-7.24M
1週間 パフォーマンス:
-3.27%
1か月 パフォーマンス:
-60.63%
6か月 パフォーマンス:
-92.06%
1年 パフォーマンス:
-49.01%
1日の値動き範囲:
$1.41
$1.51
1週間の範囲:
$1.29
$1.699
52週間の値動き範囲:
$1.29
$99.75
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
名前
Novabay Pharmaceuticals Inc
セクター
電話
510-899-8800
住所
2000 Powell Street, Suite 1150, Emeryville, CA
Compare NBY vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
1.48 | 38.14M | 4.75M | -7.83M | -7.24M | 0.2177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-09-18 | 開始されました | Ladenburg Thalmann | Buy |
| 2018-07-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-11-15 | 繰り返されました | Laidlaw | Buy |
| 2017-06-05 | 開始されました | ROTH Capital | Buy |
| 2017-03-27 | 開始されました | Laidlaw | Buy |
| 2017-02-06 | 開始されました | Rodman & Renshaw | Buy |
| 2016-03-07 | ダウングレード | Maxim Group | Buy → Hold |
| 2015-12-14 | 繰り返されました | Maxim Group | Buy |
| 2015-04-30 | 再開されました | Maxim Group | Buy |
| 2013-03-06 | 開始されました | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | 開始されました | Dawson James | Speculative Buy |
すべてを表示
Novabay Pharmaceuticals Inc (NBY) 最新ニュース
NBY Earnings History & Surprises | EPS & Revenue Results | NOVABAY PHARMACEUTICALS INC (NYSEARCA:NBY) - ChartMill
Breakouts Watch: What are the risks of holding NovaBay Pharmaceuticals IncPortfolio Growth Summary & Weekly Market Pulse Updates - baoquankhu1.vn
Gross margin % of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
NBY SEC FilingsNovabay Pharma 10-K, 10-Q, 8-K Forms - Stock Titan
Net current asset value per share of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
NovaBay Pharmaceuticals, Inc. Earnings and Revenue – GETTEX:B9P1 - TradingView
Cash per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Price Passes Below 50-Day Moving AverageHere's What Happened - MarketBeat
Diluted net income available to common stockholders of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Debt to assets ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Tangible book value per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Net current asset value per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Enterprise value to EBITDA ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Free cash flow per share of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView
Operating income of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Price to cash flow ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Diluted shares outstanding of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Total revenue of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Free cash flow of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Enterprise value of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Operating expenses (excl. COGS) of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Number of employees of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Gross margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Operating margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Return on invested capital % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Diluted earnings per share (diluted EPS) of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
EBITDA of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Free cash flow per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
EBITDA per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Total liabilities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Debt to equity ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Cash from operating activities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Long term debt to total equity ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
NovaBay Pharmaceuticals, Inc. Earnings and Revenue – MUN:B9P1 - TradingView
EBIT of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Operating income of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Average basic shares outstanding of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Total operating expenses of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Net debt of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Total liabilities & shareholders' equities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Cost of goods sold of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Total equity of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Quick ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
NovaBay Pharmaceuticals, Inc. Cash Flow – MUN:B9P1 - TradingView
NovaBay Pharmaceuticals, Inc. Income Statement – MUN:B9P1 - TradingView
Total debt per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Net margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
NovaBay Pharmaceuticals, Inc. Balance Sheet – MUN:B9P1 - TradingView
Diluted earnings per share (diluted EPS) of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView
NovaBay Pharmaceuticals, Inc. Financial Statements – MUN:B9P1 - TradingView
NovaBay Pharmaceuticals, Inc. Dividends – MUN:B9P1 - TradingView
Novabay Pharmaceuticals Inc (NBY) 財務データ
収益
当期純利益
現金流量
EPS
3.69%
0.68%
大文字化:
|
ボリューム (24 時間):